Renal and Cardiac Effects of DPP4 Inhibitors – from Preclinical Development to Clinical Research

Publisher： Karger

E-ISSN： 1423-0143|36|1|65-84

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.36, Iss.1, 2012-08, pp. : 65-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes

By  

Cardiorenal Medicine, Vol. 3, Iss. 1, 2013-03 ,pp. : 48-56

Karger

Access to resources Recommend Favorite

Renal Effects of COX-2-Selective Inhibitors

By  

American Journal of Nephrology, Vol. 21, Iss. 1, 2001-03 ,pp. : 1-15

Karger

Access to resources Recommend Favorite

Cardiac and Renal Effects of Atrasentan in Combination with Enalapril and Paricalcitol in Uremic Rats

By  

Kidney and Blood Pressure Research, Vol. 39, Iss. 4, 2014-09 ,pp. : 340-352

Karger

Access to resources Recommend Favorite

Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review

By  

American Journal of Nephrology, Vol. 45, Iss. 2, 2017-01 ,pp. : 160-169

Karger

Access to resources Recommend Favorite

Effects of Captopril on Cardiac and Renal Damage, and Metabolic Alterations in the Nitric Oxide-Deficient Hypertensive Rat

By  

Kidney and Blood Pressure Research, Vol. 28, Iss. 4, 2005-12 ,pp. : 243-250

Karger

Access to resources Recommend Favorite